Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Aethlon Medical (AEMD) Equity Ratio (2016 - 2025)

Aethlon Medical filings provide 15 years of Equity Ratio readings, the most recent being 0.7 for Q1 2025.

  • On a quarterly basis, Equity Ratio changed 0.45% to 0.7 in Q1 2025 year-over-year; TTM through Mar 2025 was 0.7, a 0.45% change, with the full-year FY2025 number at 0.7, changed 0.45% from a year prior.
  • Equity Ratio hit 0.7 in Q1 2025 for Aethlon Medical, up from 0.66 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.96 in Q3 2021 to a low of 0.66 in Q4 2024.
  • Median Equity Ratio over the past 5 years was 0.83 (2022), compared with a mean of 0.82.
  • Biggest five-year swings in Equity Ratio: rose 6.45% in 2021 and later dropped 18.72% in 2024.
  • Aethlon Medical's Equity Ratio stood at 0.94 in 2021, then decreased by 11.12% to 0.83 in 2022, then decreased by 12.53% to 0.73 in 2023, then dropped by 8.92% to 0.66 in 2024, then rose by 4.81% to 0.7 in 2025.
  • The last three reported values for Equity Ratio were 0.7 (Q1 2025), 0.66 (Q4 2024), and 0.68 (Q3 2024) per Business Quant data.